CATALOGO DEI PRODOTTI DELLA RICERCA

ZECCHETTO, CAMILLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.686
NA - Nord America 1.678
AS - Asia 1.121
SA - Sud America 172
AF - Africa 37
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.699
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.636
RU - Federazione Russa 742
SG - Singapore 396
CN - Cina 345
IT - Italia 245
BR - Brasile 143
GB - Regno Unito 143
DE - Germania 140
VN - Vietnam 127
HK - Hong Kong 93
IE - Irlanda 91
SE - Svezia 82
FR - Francia 75
FI - Finlandia 59
KR - Corea 37
CA - Canada 33
IN - India 26
NL - Olanda 23
JP - Giappone 18
BD - Bangladesh 14
AR - Argentina 13
AT - Austria 13
UA - Ucraina 13
ES - Italia 12
TR - Turchia 12
PL - Polonia 10
ID - Indonesia 9
ZA - Sudafrica 9
BE - Belgio 6
BJ - Benin 6
NG - Nigeria 6
SA - Arabia Saudita 6
TG - Togo 6
CZ - Repubblica Ceca 5
AU - Australia 4
EC - Ecuador 4
IQ - Iraq 4
JO - Giordania 4
LT - Lituania 4
MX - Messico 4
PT - Portogallo 4
UZ - Uzbekistan 4
HR - Croazia 3
NO - Norvegia 3
PK - Pakistan 3
PY - Paraguay 3
TH - Thailandia 3
VE - Venezuela 3
AM - Armenia 2
AZ - Azerbaigian 2
CL - Cile 2
DZ - Algeria 2
EG - Egitto 2
GR - Grecia 2
IR - Iran 2
KZ - Kazakistan 2
LB - Libano 2
MA - Marocco 2
NP - Nepal 2
PE - Perù 2
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CH - Svizzera 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
EU - Europa 1
GI - Gibilterra 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
OM - Oman 1
PH - Filippine 1
PR - Porto Rico 1
QA - Qatar 1
RE - Reunion 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TN - Tunisia 1
UY - Uruguay 1
Totale 4.699
Salva come PNG Salva come JPEG
Città #
Moscow 302
Ashburn 294
Dallas 255
Singapore 226
Chandler 182
San Jose 145
Hong Kong 92
Dublin 91
Southend 86
Verona 70
Beijing 58
Munich 58
The Dalles 55
Ho Chi Minh City 46
New York 37
Los Angeles 33
Jacksonville 31
Helsinki 27
São Paulo 27
Turku 25
Jinan 24
Council Bluffs 22
Woodbridge 22
Hanoi 21
Tianjin 20
Lawrence 19
London 19
Princeton 19
Milan 18
Houston 17
Orem 17
Wilmington 17
Rome 16
Montreal 15
Shenyang 15
Tokyo 15
Buffalo 14
Frankfurt am Main 14
Taiyuan 14
Columbus 13
Denver 13
Toronto 13
Atlanta 12
Santa Clara 12
Sindelfingen 12
Seattle 10
Ann Arbor 9
Barnet 9
Da Nang 9
Redondo Beach 9
Stockholm 9
Taizhou 9
Amsterdam 8
Chicago 8
Seoul 8
Washington 8
Changsha 7
Jakarta 7
Johannesburg 7
Kent 7
Madrid 7
Monza 7
Paris 7
Phoenix 7
Redwood City 7
Vienna 7
Zhengzhou 7
Cotonou 6
Fuzhou 6
Haikou 6
Hangzhou 6
Lomé 6
Nanjing 6
Nuremberg 6
Warsaw 6
Abuja 5
Bologna 5
Boston 5
Brussels 5
Chennai 5
Guangzhou 5
Hebei 5
Mumbai 5
Nanchang 5
Treviso 5
Amman 4
Brasília 4
Brooklyn 4
Dhaka 4
Fairfield 4
Haiphong 4
Lancaster 4
Marseille 4
Ningbo 4
Redmond 4
Rio de Janeiro 4
Riyadh 4
San Francisco 4
Boardman 3
Brescia 3
Totale 2.882
Salva come PNG Salva come JPEG
Nome #
A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma 291
A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial 250
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report 249
Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling 235
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 232
Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer 204
A phase II trial of the FGFR inhibitor pemigatinib in patients with metastatic esophageal-gastric junction/gastric cancer trastuzumab resistant: the FiGhTeR trial 203
Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients 193
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic 191
Plasma Interleukin-8 is a biomarker for TAK1 activation and predicts resistance to nanoliposomal irinotecan in patients with gemcitabine-refractory pancreatic cancer 183
Novel Biomarkers for Prediction of Response to Preoperative Systemic Therapies in Gastric Cancer 179
Modulating TAK1 expression inhibits YAP and TAZ oncogenic functions in pancreatic cancer 175
Role of next-generation genomic sequencing in targeted agents repositioning for pancreaticoduodenal cancer patients 173
Clinicogenomic Analysis of FGFR2-Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib 171
Multicenter Retrospective Analysis of Second-Line Therapy after Gemcitabine Plus Nab-Paclitaxel in Advanced Pancreatic Cancer Patients 162
Targeting KRAS: The Elephant in the Room of Epithelial Cancers 156
Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion 155
Autotaxin Secretion Is a Stromal Mechanism of Adaptive Resistance to TGFβ Inhibition in Pancreatic Ductal Adenocarcinoma 148
Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer 146
Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trial 137
Pemigatinib, a potent inhibitor of FGFRs for the treatment of cholangiocarcinoma 135
Clinical Response to Futibatinib in Patients with High-Level FGFR2-Amplified Advanced Gastric Cancer: Two Case Reports 133
YAP Activation Is Associated with a Worse Prognosis of Poorly Cohesive Gastric Cancer 124
Integration of liposomal irinotecan in the first-line treatment of metastatic pancreatic cancer: try to do not think about the white bear 115
Current Role and Future Perspectives of Immunotherapy and Circulating Factors in Treatment of Biliary Tract Cancers 112
Safety and activity of the TGF beta receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer 109
Is There Room for Liposomal Irinotecan in Biliary Tract Cancer? A Meta-analysis of Randomised Trials 104
The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma 86
Totale 4.751
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.639
article - articoli 16.639
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.278
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 0 0 0 10
2021/2022225 18 83 8 20 3 6 0 13 7 4 12 51
2022/2023498 24 63 36 81 37 137 0 30 63 7 13 7
2023/2024392 7 25 23 48 34 64 62 39 8 25 43 14
2024/2025797 37 32 40 123 37 38 79 37 74 35 108 157
2025/20262.443 135 120 239 407 627 151 228 104 203 162 35 32
Totale 4.751